For instance, DNMT inhibitors finely modulate the macrophages immunosuppressive activity and promote the anti-tumor activity of T cells (Stone et al., 2017), while JQ1 a BET inhibitor reduces the expression levels of PD-L1 on tumor cells and immune cells present in TME (Zhu et al., 2016). This evidence concerns the gene CD274 and neoplasm.